These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 361314

  • 1. Complement-mediated immune mechanisms in renal infection. II. Effect of decomplementation.
    Miller TE, Phillips S, Simpson IJ.
    Clin Exp Immunol; 1978 Jul; 33(1):115-21. PubMed ID: 361314
    [Abstract] [Full Text] [Related]

  • 2. [Defense mechanisms of the macro-organism in bacteriuria in chronic pyelonephritis].
    Falkenhagen U, Wendt M, Hilbert R, Zingler G.
    Z Urol Nephrol; 1986 Nov; 79(11):619-27. PubMed ID: 3551386
    [Abstract] [Full Text] [Related]

  • 3. Studies of the mechanism of bacterial resistance to complement-mediated killing. V. IgG and F(ab')2 mediate killing of E. coli 0111B4 by the alternative complement pathway without increasing C5b-9 deposition.
    Joiner KA, Goldman RC, Hammer CH, Leive L, Frank MM.
    J Immunol; 1983 Nov; 131(5):2563-9. PubMed ID: 6355296
    [Abstract] [Full Text] [Related]

  • 4. Effects of decomplementation on mercuric chloride-induced glomerulonephritis in Brown-Norway rats.
    Capron M, Bascou C, Vial MC, Grossetete J, Hinglais N, Girard JF, Druet P.
    Clin Exp Immunol; 1982 Sep; 49(3):611-7. PubMed ID: 6216993
    [Abstract] [Full Text] [Related]

  • 5. [Serum resistance of Escherichia coli and serum bactericidal activity in chronic pyelonephritis].
    Falkenhagen U, Handschuck I, Nimmich W, Zingler G, Naumann G.
    Z Urol Nephrol; 1984 Nov; 77(11):629-38. PubMed ID: 6395557
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Studies on the mechanism of bacterial resistance to complement-mediated killing. VI. IgG increases the bactericidal efficiency of C5b-9 for E. coli 0111B4 by acting at a step before C5 cleavage.
    Joiner KA, Goldman RC, Hammer CH, Leive L, Frank MM.
    J Immunol; 1983 Nov; 131(5):2570-5. PubMed ID: 6355297
    [Abstract] [Full Text] [Related]

  • 8. Experimental Escherichia coli 06 infection in mice. IV. On the relative importance of complement factors and antibodies for the host defence.
    Ahlstedt S.
    Acta Pathol Microbiol Scand C; 1981 Feb; 89(1):23-8. PubMed ID: 7027735
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The effects of cobra venom factor, an inhibitor of the complement system, on the sequence of morphological events in the rat kidney in experimental pyelonephritis.
    Sullivan MJ, Harvey RA, Shimamura T.
    Yale J Biol Med; 1977 Feb; 50(3):267-73. PubMed ID: 329591
    [Abstract] [Full Text] [Related]

  • 12. The classical complement pathway plays a critical role in the opsonisation of uropathogenic Escherichia coli.
    Li K, Sacks SH, Sheerin NS.
    Mol Immunol; 2008 Feb; 45(4):954-62. PubMed ID: 17870166
    [Abstract] [Full Text] [Related]

  • 13. Interaction of turkey complement with Escherichia coli isolated from turkeys.
    Ellis MG, Arp LH, Lamont SJ.
    Am J Vet Res; 1989 Aug; 50(8):1285-9. PubMed ID: 2675694
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Deficient serum bactericidal activity against Escherichia coli in patients with cirrhosis of the liver.
    Fierer J, Finley F.
    J Clin Invest; 1979 May; 63(5):912-921. PubMed ID: 376551
    [Abstract] [Full Text] [Related]

  • 19. The interaction of Escherichia coli with normal human serum: the kinetics of serum-mediated lipopolysaccharide release and its dissociation from bacterial killing.
    Tesh VL, Duncan RL, Morrison DC.
    J Immunol; 1986 Aug 15; 137(4):1329-35. PubMed ID: 3525676
    [Abstract] [Full Text] [Related]

  • 20. Protection against experimental pyelonephritis by antibodies to pili.
    Silverblatt FJ, Weinstein R, Rene P.
    Scand J Infect Dis Suppl; 1982 Aug 15; 33():79-82. PubMed ID: 6127805
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.